Erdafitinib (BALVERSA)
Ended Awarded Last action
- Contract number
- 36C26022F0339
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $55,141
Award facts
- Contract value 100% obligated
- $55,140.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Horsham, PA 19044, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$34,859 | |
| Funding Only Action | $0 | |
| Original award | $90,000 |
About this award
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a $55,140.61 delivery order against the Pharmaceuticals and Drugs Master Schedule contract to Janssen Biotech, Inc. The firm fixed price order is for the drug erdafitinib under the trade name BALVERSA and has a period of performance from June 17, 2022 through January 31, 2023. The place of performance is Janssen's facility in Horsham, Pennsylvania. No subcontractors or set aside designations were identified. This order will support VHA's healthcare programs by providing cancer treatment medications to veterans served by VISN 20.
Quick answers
Who was awarded contract 36C26022F0339?
36C26022F0339 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on June 17, 2022.
How much is contract 36C26022F0339 worth?
The government has obligated $55,141 on 36C26022F0339.
Is contract 36C26022F0339 an order under another contract?
Yes. 36C26022F0339 is a delivery order under 36F79719D0217, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26022F0339 competed?
The extent of competition for 36C26022F0339 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award